← Every company
Regeneron Pharmaceuticals Inc Planned Sales
Before an insider at Regeneron Pharmaceuticals Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
REGN insider trades →Notices on file
1
Insiders
1
Shares noticed
4.1K
permission to sell, not sales
Estimated value
$3.2M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Andrew J MurphyOfficer2026-10-144.1K sh<0.01% | $3.2M |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on REGN
Company overviewEverything on REGN in one place, with the price.SEC filingsWhat REGN's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat REGN's own officers and directors buy and sell.Executive payWhat REGN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in REGN.Funds holding itWhich funds and ETFs hold REGN, and how big a bet.LobbyingWhat REGN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on REGN's account, and who they worked for.Federal contractsWhat federal agencies pay REGN.PatentsWhat REGN is filing at the patent office.